Precision Optics Corporation (POCI) Liabilities and Shareholders Equity (2011 - 2026)
Precision Optics Corporation (POCI) posted quarterly Liabilities and Shareholders Equity of $33.7 million for Q1 2026, up 71.67% year-over-year from $19.6 million in Q1 2025, and up 47.13% quarter-over-quarter from $22.9 million in Q4 2025.
Precision Optics Corporation (POCI) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Precision Optics Corporation (POCI) has reported Liabilities and Shareholders Equity for 16 consecutive years, with $33.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 71.67% year-over-year to $33.7 million; the TTM figure through Mar 2026 stood at $98.8 million (up 38.54% YoY), while the FY2025 annual figure was $19.8 million, up 17.02% from the prior year.
- Liabilities and Shareholders Equity grew to $33.7 million in Q1 2026 per POCI's latest filing, from $22.9 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $33.7 million in Q1 2026 and bottomed at $16.7 million in Q2 2022.
- Historically, Liabilities and Shareholders Equity has averaged $19.5 million across 5 years, with a median of $18.2 million in 2023.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 192.37% — and 2024, when it dropped 14.33%.
- Precision Optics Corporation's Liabilities and Shareholders Equity stood at $17.5 million in 2022, then advanced by 1.31% to $17.7 million in 2023, then fell by 1.06% to $17.5 million in 2024, then soared by 30.75% to $22.9 million in 2025, then surged by 47.13% to $33.7 million in 2026.
- Business Quant data shows POCI's Liabilities and Shareholders Equity at $33.7 million in Q1 2026, $22.9 million in Q4 2025, and $22.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Precision Optics Corporation | 35.46 Mn | 24.78 Mn | 2.06 Mn | 33.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.69 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 22.38 Mn |
| Jun 30, 2025 | 19.79 Mn |
| Mar 31, 2025 | 19.62 Mn |
| Dec 31, 2024 | 17.51 Mn |
| Sep 30, 2024 | 17.24 Mn |
| Jun 30, 2024 | 16.91 Mn |
| Mar 31, 2024 | 18.27 Mn |
| Dec 31, 2023 | 17.70 Mn |
| Sep 30, 2023 | 19.07 Mn |
| Jun 30, 2023 | 19.74 Mn |
| Mar 31, 2023 | 18.19 Mn |
| Dec 31, 2022 | 17.47 Mn |
| Sep 30, 2022 | 17.17 Mn |
| Jun 30, 2022 | 16.70 Mn |
| Mar 31, 2022 | 17.27 Mn |
| Dec 31, 2021 | 16.89 Mn |
| Sep 30, 2021 | 7.10 Mn |
| Jun 30, 2021 | 6.26 Mn |